A link between legalized marijuana and reduced opioid deaths
Opioid-related deaths decreased following the legalization of recreational marijuana in Colorado, according to a study led by a public health researcher from UNT Health Science Center.
The study, published in the American Journal of Public Health, showed a 6 percent reduction in opioid-related deaths in the two years after Colorado’s marijuana legalization, reversing the previous upward trend.
“As policy makers continue to grapple with both the growing opioid crisis and the rapidly changing landscape of marijuana laws in the U.S., scientific evidence is needed to help inform policy decisions to combat this disturbing upward trend in opioid-related deaths,” said Melvin D. Livingston, PhD, Assistant Professor at UNTHSC and lead author of the study.
Illegal and legally prescribed opioids now account for nearly 30,000 deaths a year in the United States, and the Centers for Disease Control and Prevention say that 91 Americans die every day from an opioid overdose. CDC data shows that opioid deaths from prescription drugs, heroin and synthetics like fentanyl have more than quadrupled since 1999.
In a July report to the White House, the U.S. Commission on Combating Drug Addiction and the Opioid Crisis emphasized the severity of the problem, calling America “a nation in crisis.”
The researchers analyzed Colorado data covering a 15-year period from 2000 to 2015 to compare changes in the number of opioid-related deaths before and after recreational marijuana sale and use was legalized.
“As of 2016, eight states and Washington DC have legalized recreational marijuana. While we found an apparent public health benefit in short-term reduction of opioid-related deaths following Colorado’s legalization, it’s important to note that expanded, legalized marijuana can also be associated with significant potential harms,” Dr. Livingston said.
“For policymakers to weigh decisions balancing potential beneficial and detrimental effects of these laws, researchers must continue to examine the full range of health outcomes through further study,” he said.
Co-authors of the study were Tracey E. Barnett, PhD, Associate Professor and Associate Dean for Academic Affairs at UNTHSC’s School of Public Health; Chris Delcher, PhD, from the University of Florida; and Alex C. Wagenaar, PhD, from Emory University.
By Steven Bartolotta In 2007, TCOM’s Dr. Rita Patterson and Dr. Jennifer Wayne, a professor at Virginia Tech, recognized the need for women in the field of bioengineering to meet together, network, mentor and increase the representation of women in the field. Thus the ASME Bioengineering...Read more
Jun 23, 2021
A growing trove of data to help scientists understand the biology of Alzheimer’s disease among diverse populations within the context of sociocultural, behavioral and environmental factors is now available through the Institute for Translational Research at The University of North Te...Read more
Jun 22, 2021
By Diane Smith-Pinckney The embroidery on Vic Holmes’ black scrubs identify him as a physician assistant and an ally to LGBTQ+ patients. The words, stitched under a rainbow-colored Caduceus pin and near his heart, read: “Vic Holmes, PA-C, He/Him/His, Family Medicine.” Pronouns are...Read more
Jun 21, 2021
By Sally Crocker Katie Pelch, PhD, wants you to know what’s in our environment and how the chemicals we’re exposed to every day may affect our health. Dr. Pelch is a part-time Assistant Professor, Department of Biostatistics and Epidemiology, in the HSC School of Public Health (SPH), where...Read more
Jun 21, 2021